How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Investopedia / Joules Garcia A QDRO allows a court to allocate retirement assets during a ...

The global water agenda is outdated and narrow and is framed mainly as a downstream impact sector. Scientists must step up to help the world recognize water as an opportunity sector and to design a ...

Liquid biopsy testing: Impact on treatment assignment and survival in a community-based oncology practice—A real-world experience. This is an ASCO Meeting Abstract from the 2021 ASCO Annual Meeting I.

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...